Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Clinical trial NCT07582159 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07582159
- Sponsor
- City of Hope Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-19
- Primary completion
- 2029-04-14
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.